For a product to be approved in Canada, a manufacturing industry has to file a new drug submission. The issue that a drug is available in the U.S. and not available in Canada may be because the company has decided not to file the new drug submission here in Canada.
You know that in the past we've had a backlog of submissions, but we are at a stage right now wherein we are anticipating eliminating the backlog by 2009. So within the next year there will be a possibility for industry to be filing a new drug submission for approval in both countries at the same time.
The fact that we are lagging behind and do not have those types of drugs has been really a regulatory process issue up to now, but there have been process improvements put in place to make sure that in our market we create an environment that is conducive to competitiveness coming into Canada.